Evidence map›Paper›PMID 38422092›Full record

ArticlePLOS global public health2024

Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys: Time for household-wide interventions?

Yohhei Hamada, Matteo Quartagno, Irwin Law, Farihah Malik, Frank Adae Bonsu, Ifedayo M O Adetifa, Yaw Adusi-Poku, Umberto D'Alessandro, Adedapo Olufemi Bashorun, Vikarunnessa Begum and 57 more

Open access · goldAbstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Adverse pregnancy outcomes and complications of tuberculosis in pregnant women.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

67 authors at 20 institutions in 18 countries.

Yohhei HamadaInstitute for Global Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-9845-4267
Matteo QuartagnoMRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
Irwin LawGlobal Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Farihah MalikUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0003-2752-5926
Frank Adae BonsuNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Ifedayo M O AdetifaDisease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, Gambia.
Yaw Adusi-PokuNational Tuberculosis Programme, Ghana Health Service, Accra, Ghana.
Umberto D'AlessandroDisease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, Gambia.
Adedapo Olufemi BashorunDisease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, Gambia.
Vikarunnessa BegumWorld Health Organization, Country Office for Bangladesh, Dhaka, Bangladesh.
Dina Bisara LolongNational Research and Innovation Agency, Jakarta, Indonesia.
Tsolmon BoldooTuberculosis Surveillance and Research Department, National Center for Communicable Disease, Ulaanbaatar, Mongolia.
Themba DlaminiEswatini National Tuberculosis Program, Ministry of Health, Mbabane, Eswatini.
Simon DonkorDisease Control and Elimination Theme, Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, Gambia.
Bintari DwihardianiCenter for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia.
Saidi EgwagaTuberculosis and Leprosy Programme, Ministry of Health and Social Welfare, Dodoma, United Republic of Tanzania.
Muhammad N FaridExpert TB Committee, Jakarta, Indonesia.
Anna Marie Celina G GarfinNational TB Control Program, Department of Health, Manila, Philippines.
Donna Mae G GaviolaNational TB Control Program, Department of Health, Manila, Philippines.
Mohammad Mushtuq HusainInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Farzana IsmailCentre for Tuberculosis: National Institute for Communicable Diseases, a Division of the National Health Laboratory Services, Johannesburg, South Africa.
Mugagga KaggwaWorld Health Organization, Country Office for Uganda, Kampala, Uganda.
Deus V KamaraTuberculosis and Leprosy Programme, Ministry of Health and Social Welfare, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0002-2141-0696
Samuel KasoziNational Tuberculosis Control Programme, Ministry of Health, Kampala, Uganda.
Kruger KaswaswaNational Tuberculosis Programme, Ministry of Health, Lilongwe, Malawi.
Bruce KirengaMakerere University Lung Institute, Kampala, Uganda.
Eveline KlinkenbergDepartment of Global Health, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Zuweina KondoTuberculosis and Leprosy Programme, Ministry of Health and Social Welfare, Dodoma, United Republic of Tanzania.
Adebola LawansonNational Tuberculosis and Leprosy Control Programme, Federal Ministry of Health, Abuja, Nigeria.
David MachequeNational Tuberculosis Program, Ministry of Health, Maputo, Mozambique.
Ivan ManhiçaNational Tuberculosis Program, Ministry of Health, Maputo, Mozambique.
Llang Bridget Maama-MaimeNational TB and Leprosy Programme, Ministry of Health, Maseru, Lesotho.
Sayoki MfinangaInstitute for Global Health, University College London, London, United Kingdom.ORCID https://orcid.org/0000-0001-9067-2684
Sizulu MoyoHuman and Social Capabilities Division, Human Sciences Research Council, Pretoria, South Africa.
James MpungaNational Tuberculosis Programme, Ministry of Health, Lilongwe, Malawi.
Thuli MthiyaneSouth African Medical Research Council, Cape Town, South Africa.
Dyah Erti MustikawatiMinistry of Health, Jakarta, Indonesia.
Lindiwe MvusiNational Department of Health, Pretoria, South Africa.
Hoa Binh NguyenNational Tuberculosis Programme, Hanoi, Viet Nam.
Hai Viet NguyenNational Tuberculosis Programme, Hanoi, Viet Nam.ORCID https://orcid.org/0000-0002-1547-6541
Lamria PangaribuanMinistry of Health, Jakarta, Indonesia.
Philip PatrobasWorld Health Organization, Country Office for Nigeria, Abuja, Nigeria.
Mahmudur RahmanInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.ORCID https://orcid.org/0000-0001-8577-8281
Mahbubur RahmanInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Mohammed Sayeedur RahmanWorld Health Organization, Country Office for Bangladesh, Dhaka, Bangladesh.ORCID https://orcid.org/0000-0002-0276-9986
Thato RaletingNational TB and Leprosy Programme, Ministry of Health, Maseru, Lesotho.
Pandu RionoDepartment of Biostatistics and Population, Faculty of Public Health, University of Indonesia, Depok, Indonesia.
Nunurai RuswaNational TB and Leprosy Programme, Ministry of Health and Social Services, Windhoek, Namibia.
Elizeus RutebemberwaDepartment of Health Policy, Planning and Management, Makerere University School of Public Health, Kampala, Uganda.
Mugabe Frank RwabinumiMakerere University Lung Institute, Kampala, Uganda.
Mbazi SenkoroNational Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, United Republic of Tanzania.ORCID https://orcid.org/0000-0003-1391-4197
Ahmad Raihan SharifInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Welile SikhondzeEswatini National Tuberculosis Program, Ministry of Health, Mbabane, Eswatini.
Charalambos SismanidisGlobal Tuberculosis Programme, World Health Organization, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-5338-3952
Tugsdelger SovdDepartment of Monitoring and Evaluation and Internal Audit, Ministry of Health, Ulaanbaatar, Mongolia.
Turyahabwe StaviaNational Tuberculosis Control Programme, Ministry of Health, Kampala, Uganda.
Sabera SultanaWorld Health Organization, Country Office for Bangladesh, Dhaka, Bangladesh.
Oster SurianiMinistry of Health, Jakarta, Indonesia.
Albertina Martha ThomasNational TB and Leprosy Programme, Ministry of Health and Social Services, Windhoek, Namibia.
Kristina TobingNational Research and Innovation Agency, Jakarta, Indonesia.
Martie Van der WaltSouth African Medical Research Council, Cape Town, South Africa.
Simon WalusimbiMakerere University Lung Institute, Kampala, Uganda.
Mohammad Mostafa ZamanWorld Health Organization, Country Office for Bangladesh, Dhaka, Bangladesh.
Katherine FloydGlobal Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Andrew CopasInstitute for Global Health, University College London, London, United Kingdom.
Ibrahim AbubakarInstitute for Global Health, University College London, London, United Kingdom.
Molebogeng X RangakaInstitute for Global Health, University College London, London, United Kingdom.
Institute of Epidemiology, Disease Control and Research · BDMakerere University · UGUniversity College London · GBMinistry of Health · IDMinistry of Health and Social Welfare · TZMRC Unit the Gambia · GMWorld Health Organization · CHWorld University of Bangladesh · BDDepartment of Health · PHGhana Health Service · GHMinistry of Health · SZMinistry of Health · MZMinistry of Health · UGMinistry of Health · LSMinistry of Health · MWMinistry of Health and Social Services · NANational Research and Innovation Agency · IDSouth African Medical Research Council · ZAAmsterdam University Medical Centers · NLDepartment of Health · ZA

Funding

World Health Organization 001
6 · The paper itself

Abstract

Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant data meta-analysis of national TB prevalence surveys to determine whether NCD cluster in members of households with TB. We identified eligible surveys that reported at least one NCD or NCD risk factor through the archive maintained by the World Health Organization and searching in Medline and Embase from 1 January 2000 to 10 August 2021, which was updated on 23 March 2023. We compared the prevalence of NCD and their risk factors between people who do not have TB living in households with at least one person with TB (members of households with TB), and members of households without TB. We included 16 surveys (n = 740,815) from Asia and Africa. In a multivariable model adjusted for age and gender, the odds of smoking was higher among members of households with TB (adjusted odds ratio (aOR) 1.23; 95% CI: 1.11-1.38), compared with members of households without TB. The analysis did not find a significant difference in the prevalence of alcohol drinking, diabetes, hypertension, or BMI between members of households with and without TB. Studies evaluating household-wide interventions for smoking to reduce its dual impact on TB and NCD may be warranted. Systematically screening for NCD using objective diagnostic methods is needed to understand the actual burden of NCD and inform comprehensive interventions.

Identifiers

PMID38422092
PMCPMC10903843
OpenAlexW4392283578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.